Donga-ST announced that they made a licensing-out contract of biosimilar 'DA-3880' in Japan
(Yakup Shinmoon)
On Jan 22, Donga-ST announced that they made a licensing-out contract of biosimilar 'DA-3880' that SKK (Sanwa Kagaku Kenkyusho) and Donga-ST are developing. Through the contract, SKK and bio-venture company, GTS (Gene Techno Science) will co-develop 'DA-3880' in Japan and af...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
